Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study^*

C. R. Frei University of Texas at Austin, Austin, TX, USA; University of Texas Health Science Center at San Antonio, San Antonio, TX, USACorrespondence[email protected]

T. C. Jaso Seton Family of Hospitals, Austin, TX, USA

E. M. Mortensen University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; South Texas Veterans Healthcare System, San Antonio, TX, USA

M. I. Restrepo University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; South Texas Veterans Healthcare System, San Antonio, TX, USA

M. K. Raut Ortho-McNeil Janssen Scientific Affairs, LLC, Raritan, NJ, USA

C. U. Oramasionwu University of Texas at Austin, Austin, TX, USA; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

A. D. Ruiz University of Texas at Austin, Austin, TX, USA; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

B. R. Makos University of Texas at Austin, Austin, TX, USA; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

J. L. Ruiz University of Texas at Austin, Austin, TX, USA

R. T. Attridge University of Texas at Austin, Austin, TX, USA; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

S. H. Mody Ortho-McNeil Janssen Scientific Affairs, LLC, Raritan, NJ, USA

A. Fisher Ortho-McNeil Janssen Scientific Affairs, LLC, Raritan, NJ, USA

J. R. Schein Ortho-McNeil Janssen Scientific Affairs, LLC, Raritan, NJ, USA

show all

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study^*

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study*

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study^*